Abiopharma

Cellectar Biosciences to Present Data in Poster Presentation at the American Association for Cancer Research Special Conference on Advances in Pancreatic Cancer Research

Madrigal Pharmaceuticals to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

Twist Bioscience to Present at Baird 2025 Global Healthcare Conference

Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025

vTv Therapeutics to Participate in Upcoming September Investor Conferences

Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025

electroCore Appoints Elena Bonfiglioli to Board of Directors

Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program

STRATA Skin Sciences Announces Pricing of $2.42 Million Registered Direct Offering of Common Stock Priced At-Market Under Nasdaq Rules

CoyaTherapeutics - Coya Therapeutics to Participate at Upcoming September Investor Conferences

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwrights 27th Annual Global Investment Conference on Monday, September 8th

New Form 8-K - MIMEDX GROUP, INC. Filed: 2025-09-03 AccNo: 0001376339-25-000093 Size: 1 MB Item 7.01: Regulation FD Disclosure

60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference

Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program